| 5722 |
English |
How NTEP can support Private Practitioners/Hospitals in TB Treatment Services |
Final Review |
|
shwetamurthy625@gmail.com |
RakeshPS |
1 month 1 week |
| 5723 |
English |
How NTEP can support Private Practitioners/Hospitals in Public Health Actions |
Final Review |
|
shwetamurthy625@gmail.com |
RakeshPS |
1 month 1 week |
| 5724 |
English |
How NTEP can support Private Practitioners/Hospitals in TB Prevention and care |
Final Review |
|
shwetamurthy625@gmail.com |
RakeshPS |
1 month 1 week |
| 1399 |
English |
Intended Use of TrueNAT MTB and TrueNAT MTB Rif Dx Assay |
Published on LMS |
Link |
NimishaArora |
Abhimanyu |
1 month 1 week |
| 556 |
English |
Fixed Dose Combinations [FDC]s |
Published on LMS |
Link |
Tonmoy |
Abhimanyu |
1 month 1 week |
| 556 |
Gujarati |
Fixed Dose Combinations [FDC]s |
Under Development |
|
Tonmoy |
Abhimanyu |
1 month 1 week |
| 556 |
Hindi |
Fixed Dose Combinations [FDC]s |
Approved |
|
Tonmoy |
Abhimanyu |
1 month 1 week |
| 556 |
Marathi |
Fixed Dose Combinations [FDC]s |
Final Review |
|
Tonmoy |
Abhimanyu |
1 month 1 week |
| 556 |
Tamil |
Fixed Dose Combinations [FDC]s |
Approved |
Link |
Tonmoy |
Abhimanyu |
1 month 1 week |
| 556 |
Telugu |
Fixed Dose Combinations [FDC]s |
Approved |
Link |
Tonmoy |
Abhimanyu |
1 month 1 week |
| 564 |
English |
Advantages of FDCs |
Depreciated |
Link |
Tonmoy |
Abhimanyu |
1 month 1 week |
| 564 |
Gujarati |
Advantages of FDCs |
Depreciated |
Link |
Tonmoy |
Abhimanyu |
1 month 1 week |
| 564 |
Marathi |
Advantages of FDCs |
Published on LMS |
Link |
Tonmoy |
Abhimanyu |
1 month 1 week |
| 564 |
Telugu |
Advantages of FDCs |
Published on LMS |
Link |
Tonmoy |
Abhimanyu |
1 month 1 week |
| 1792 |
English |
Treatment Regimen for NTM |
Published on LMS |
Link |
Archana.Singh |
Abhimanyu |
1 month 1 week |
| 2617 |
English |
Reporting of Adverse Events and Serious Adverse Events |
Published on LMS |
Link |
Archana.Singh |
Abhimanyu |
1 month 1 week |
| 1135 |
English |
Shorter Oral Bedaquiline-containing MDR/RR-TB Regimen: Treatment Extension |
Published on LMS |
Link |
Archana.Singh |
Abhimanyu |
1 month 1 week |
| 2224 |
English |
Minimum and maximum stock |
Published on LMS |
Link |
SwathiK |
SwathiK |
1 month 1 week |
| 2248 |
English |
Drugs, injectables and related supplies in NTEP |
Published on LMS |
Link |
SheetalRai |
VandhanaM |
1 month 1 week |
| 2250 |
English |
Laboratory consumables |
Published on LMS |
Link |
SheetalRai |
SwathiK |
1 month 1 week |
| 918 |
English |
Stocking Norms of Drugs and Supplies |
Published on LMS |
Link |
Namrata |
PrashantBhat |
1 month 1 week |
| 2385 |
English |
Specification of boxes |
Published on LMS |
Link |
SheetalRai |
SwathiK |
1 month 1 week |
| 2426 |
English |
Store Visits in NTEP |
Published on LMS |
Link |
NimishaArora |
Abhimanyu |
1 month 1 week |
| 5598 |
English |
Activities that can be undertaken by TB Champions |
Published on LMS |
Link |
SwathiK |
SwathiK |
1 month |
| 358 |
English |
Pathogenesis of TB |
Published on LMS |
Link |
Awele |
Abhimanyu |
1 month |
| 724 |
English |
Classification of TB on the basis of Drug Resistance |
Published on LMS |
Link |
Archana.Singh |
Abhimanyu |
1 month |
| 724 |
Gujarati |
Classification of TB on the basis of Drug Resistance |
Under Development |
Link |
Archana.Singh |
Abhimanyu |
1 month |
| 595 |
English |
Drug-Resistant Tuberculosis [DR-TB] |
Published on LMS |
Link |
Archana.Singh |
Abhimanyu |
1 month |
| 595 |
Gujarati |
Drug-Resistant Tuberculosis [DR-TB] |
Under Development |
|
Archana.Singh |
Abhimanyu |
1 month |
| 595 |
Hindi |
Drug-Resistant Tuberculosis(DR-TB) |
Approved |
|
Archana.Singh |
Abhimanyu |
1 month |
| 595 |
Marathi |
Drug-Resistant Tuberculosis(DR-TB) |
|
|
Archana.Singh |
Abhimanyu |
1 month |
| 595 |
Tamil |
Drug-Resistant Tuberculosis(DR-TB) |
Approved |
Link |
Archana.Singh |
Abhimanyu |
1 month |
| 595 |
Telugu |
Drug-Resistant Tuberculosis(DR-TB) |
Approved |
Link |
Archana.Singh |
Abhimanyu |
1 month |
| 632 |
English |
Screening for DR-TB |
Published on LMS |
Link |
Archana.Singh |
Abhimanyu |
1 month |
| 632 |
Gujarati |
Screening for DR-TB |
Under Development |
Link |
Archana.Singh |
Abhimanyu |
1 month |
| 632 |
Marathi |
Screening for DR-TB |
|
|
Archana.Singh |
Abhimanyu |
1 month |
| 632 |
Telugu |
Screening for DR-TB |
Published on LMS |
Link |
Archana.Singh |
Abhimanyu |
1 month |
| 634 |
English |
DR-TB Treatment – Patient Flow |
Published on LMS |
Link |
Awele |
Abhimanyu |
1 month |
| 634 |
Gujarati |
DR-TB Treatment – Patient Flow |
Under Development |
Link |
Awele |
Abhimanyu |
1 month |
| 634 |
Marathi |
DR-TB Treatment – Patient Flow |
Final Review |
Link |
Awele |
Abhimanyu |
1 month |
| 634 |
Telugu |
DR-TB Treatment – Patient Flow |
Approved |
Link |
Awele |
Abhimanyu |
1 month |
| 1125 |
English |
Newer Anti-TB Drugs |
Published on LMS |
Link |
NimishaArora |
Abhimanyu |
1 month |
| 1076 |
English |
Weight Band-wise Dosages of DR-TB Drugs for Adults |
Published on LMS |
Link |
Archana.Singh |
Abhimanyu |
1 month |
| 2621 |
English |
Treatment of DR-TB in Children |
Published on LMS |
Link |
SwathiK |
SwathiK |
1 month |
| 870 |
English |
99 DOTS- Features and Benefits |
Published on LMS |
Link |
Archana.Singh |
Abhimanyu |
1 month |
| 2737 |
English |
Evaluation of Stores and Stocks |
Published on LMS |
Link |
SheetalRai |
PrashantBhat |
1 month |
| 882 |
English |
Planning Process at TU level |
Final Review |
|
NimishaArora |
PrashantBhat |
1 month |
| 882 |
Marathi |
Planning Process at TU level |
Final Review |
|
NimishaArora |
PrashantBhat |
1 month |
| 882 |
Telugu |
Planning Process at TU level |
Final Review |
|
NimishaArora |
PrashantBhat |
1 month |
| 927 |
English |
Drug Consumption |
Depreciated |
|
Namrata |
Abhimanyu |
1 month |
